Shares of The Cooper Firms, Inc. (NASDAQ:COO – Get Free Report) have been assigned a median ranking of “Reasonable Purchase” from the 13 rankings companies which can be at present overlaying the corporate, Marketbeat Rankings reviews. Three analysts have rated the inventory with a maintain ranking and ten have given a purchase ranking to the corporate. The common 12-month value goal amongst brokers which have coated the inventory within the final yr is $115.00.
A number of analysis companies not too long ago commented on COO. Stifel Nicolaus reissued a “purchase” ranking and issued a $115.00 value goal (up from $110.00) on shares of Cooper Firms in a analysis observe on Thursday, August twenty ninth. Wells Fargo & Firm elevated their goal value on shares of Cooper Firms from $110.00 to $115.00 and gave the corporate an “chubby” ranking in a analysis report on Thursday, August twenty ninth. Needham & Firm LLC restated a “maintain” ranking on shares of Cooper Firms in a analysis report on Thursday, August twenty ninth. Piper Sandler elevated their value goal on shares of Cooper Firms from $115.00 to $120.00 and gave the corporate an “chubby” ranking in a report on Thursday, August twenty ninth. Lastly, Morgan Stanley raised their goal value on shares of Cooper Firms from $95.00 to $104.00 and gave the inventory an “equal weight” ranking in a analysis observe on Tuesday, September tenth.
Learn Our Newest Inventory Report on Cooper Firms
Cooper Firms Inventory Down 0.8 %
Shares of NASDAQ COO opened at $106.97 on Tuesday. The agency has a market cap of $21.30 billion, a price-to-earnings ratio of 62.92, a price-to-earnings-growth ratio of two.63 and a beta of 0.98. The corporate’s 50-day easy transferring common is $100.89 and its 200-day easy transferring common is $95.92. The corporate has a fast ratio of 1.18, a present ratio of 1.99 and a debt-to-equity ratio of 0.33. Cooper Firms has a 52-week low of $75.93 and a 52-week excessive of $112.38.
Cooper Firms (NASDAQ:COO – Get Free Report) final posted its quarterly earnings knowledge on Wednesday, August twenty eighth. The medical gadget firm reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Firms had a return on fairness of 9.08% and a web margin of 9.45%. The corporate had income of $1 billion for the quarter, in comparison with analysts’ expectations of $997.30 million. Throughout the identical interval within the earlier yr, the agency posted $0.84 EPS. Cooper Firms’s income was up 7.8% in comparison with the identical quarter final yr. Equities analysts predict that Cooper Firms will submit 3.65 EPS for the present fiscal yr.
Insider Shopping for and Promoting at Cooper Firms
In different Cooper Firms information, CFO Brian G. Andrews offered 24,788 shares of Cooper Firms inventory in a transaction dated Thursday, September fifth. The inventory was offered at a median value of $105.90, for a complete worth of $2,625,049.20. Following the completion of the transaction, the chief monetary officer now straight owns 6,614 shares of the corporate’s inventory, valued at roughly $700,422.60. The transaction was disclosed in a submitting with the SEC, which is accessible by this hyperlink. In different Cooper Firms information, CFO Brian G. Andrews offered 24,788 shares of the agency’s inventory in a transaction that occurred on Thursday, September fifth. The shares have been offered at a median value of $105.90, for a complete worth of $2,625,049.20. Following the completion of the transaction, the chief monetary officer now owns 6,614 shares of the corporate’s inventory, valued at roughly $700,422.60. The sale was disclosed in a submitting with the Securities & Trade Fee, which is accessible by this hyperlink. Additionally, CEO Albert G. White III offered 114,992 shares of the corporate’s inventory in a transaction on Thursday, September nineteenth. The inventory was offered at a median value of $110.53, for a complete worth of $12,710,065.76. Following the sale, the chief government officer now straight owns 165,273 shares within the firm, valued at roughly $18,267,624.69. The disclosure for this sale could be discovered right here. Insiders have offered a complete of 256,373 shares of firm inventory valued at $27,637,427 during the last quarter. 2.00% of the inventory is owned by firm insiders.
Institutional Inflows and Outflows
A number of institutional traders and hedge funds have not too long ago added to or decreased their stakes in COO. Franklin Sources Inc. lifted its place in shares of Cooper Firms by 1.2% in the course of the 4th quarter. Franklin Sources Inc. now owns 3,401 shares of the medical gadget firm’s inventory value $1,287,000 after buying a further 41 shares over the last quarter. LRI Investments LLC lifted its holdings in Cooper Firms by 4.5% in the course of the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical gadget firm’s inventory value $227,000 after shopping for a further 112 shares over the last quarter. Commonwealth Fairness Providers LLC boosted its place in shares of Cooper Firms by 0.8% in the course of the 2nd quarter. Commonwealth Fairness Providers LLC now owns 15,600 shares of the medical gadget firm’s inventory value $1,362,000 after buying a further 118 shares within the final quarter. First Horizon Advisors Inc. elevated its holdings in shares of Cooper Firms by 4.8% within the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical gadget firm’s inventory valued at $236,000 after buying a further 125 shares over the last quarter. Lastly, American Worldwide Group Inc. raised its place in shares of Cooper Firms by 1.0% in the course of the 4th quarter. American Worldwide Group Inc. now owns 13,229 shares of the medical gadget firm’s inventory value $5,006,000 after buying a further 137 shares within the final quarter. Institutional traders and hedge funds personal 24.39% of the corporate’s inventory.
Cooper Firms Firm Profile
The Cooper Firms, Inc, along with its subsidiaries, develops, manufactures, and markets contact lens wearers. The corporate operates in two segments, CooperVision and CooperSurgical. The CooperVision phase gives spherical lense, together with lenses that right close to and farsightedness; and toric and multifocal lenses comprising lenses correcting imaginative and prescient challenges, akin to astigmatism, presbyopia, and myopia within the Americas, Europe, Center East, Africa, and Asia Pacific.
See Additionally
Obtain Information & Rankings for Cooper Firms Day by day – Enter your e-mail tackle beneath to obtain a concise every day abstract of the newest information and analysts’ rankings for Cooper Firms and associated corporations with MarketBeat.com’s FREE every day e-mail publication.
